Corcept Therapeutics Incorporated (CORT) — Cash Flow Reinvestment Rate
Corcept Therapeutics Incorporated (CORT) has a Cash Flow Reinvestment Rate of 0.31x as of December 2025, reinvesting $11.84 Million (capex $50.00K plus investments $-11.79 Million) from operating cash flow of $38.45 Million. See Corcept Therapeutics Incorporated (CORT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Corcept Therapeutics Incorporated Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Corcept Therapeutics Incorporated across 11 annual periods. For the full cash flow conversion analysis, see CORT cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Corcept Therapeutics Incorporated (2015–2025)
Year-by-year capital reinvestment analysis for Corcept Therapeutics Incorporated. See Corcept Therapeutics Incorporated (CORT) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | $70.18 Million | $142.00 Million | $211.00K | ▼ -45.5% |
| 2024 | 0.91x | $179.78 Million | $198.07 Million | $2.17 Million | ▲ +103.3% |
| 2023 | 0.45x | $56.71 Million | $127.04 Million | $139.00K | ▼ -53.2% |
| 2022 | 0.95x | $114.74 Million | $120.32 Million | $413.00K | ▲ +16.8% |
| 2021 | 0.82x | $137.06 Million | $167.89 Million | $469.00K | ▲ +4.0% |
| 2020 | 0.78x | $119.26 Million | $151.97 Million | $1.24 Million | ▼ -9.3% |
| 2019 | 0.87x | $117.83 Million | $136.12 Million | $1.09 Million | ▲ +10.3% |
| 2018 | 0.78x | $90.77 Million | $115.67 Million | $298.00K | ▼ -34.9% |
| 2017 | 1.21x | $73.46 Million | $60.94 Million | $419.00K | ▲ +5613.9% |
| 2016 | 0.02x | $388.00K | $18.39 Million | $194.00K | ▼ -99.9% |
| 2015 | 23.34x | $73.05 Million | $3.13 Million | $17.00K | — |